Suppr超能文献

用于慢性肠系膜缺血的短系列腹腔镜肠系膜旁路手术

A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia.

作者信息

Kazmi Syed Sajid Hussain, Berge Simen Tveten, Sahba Mehdi, Medhus Asle Wilhelm, Sundhagen Jon Otto

机构信息

Department of Vascular Surgery, Heart, Lung and Vascular Clinic, Oslo University Hospital Aker, Oslo, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

Vasc Health Risk Manag. 2020 Mar 20;16:87-97. doi: 10.2147/VHRM.S243264. eCollection 2020.

Abstract

BACKGROUND

Laparoscopic aortomesenteric bypass may be performed to treat the chronic mesenteric ischemia patients who are not suitable for endovascular treatment. This study presents an initial experience with a limited series of laparoscopic mesenteric artery revascularization for the treatment of mesenteric ischemia.

METHODS

Chronic mesenteric ischemia (CMI) patients with previous unsuccessful endovascular treatment or with arterial occlusion and extensive calcification precluding safe endovascular treatment were offered laparoscopic mesenteric revascularization. From October 2015 until November 2018, nine patients with CMI underwent laparoscopic revascularization. In addition to demographic data and perioperative results of the treatment, graft patency was assessed with Duplex ultrasound at 1, 3, 6 and 12 months, and annually thereafter. A descriptive analysis of the data was performed.

RESULTS

All bypasses were constructed with an 8 mm ring enforced expanded polytetrafluoroethylene graft in a retrograde fashion (from infrarenal aorta or iliac artery) to either superior mesenteric artery or splenic artery (2 cases). Median operation time was 356 mins (range 247-492 mins). Five patients had a history of unsuccessful endovascular treatment. Laparoscopic technical success was 78%, and the primary open conversion rate was 22%. All laparoscopic revascularization procedures remained patent after discharge during a median follow-up time of 26 months (range 18-49 months). The primary graft patency at 30 days was 78%. Primary assisted, and secondary graft patency was 78% and 100%, respectively. Median weight gain was 2 kg (range 2-18 kg), and all patients achieved relief from postprandial pain and nausea. No mortality was observed during the follow-up period.

CONCLUSION

Laparoscopic aortomesenteric revascularization procedures for chronic mesenteric ischemia are feasible but require careful patient selection. These procedures should only be performed at referral centers by vascular surgeons with prior experience in laparoscopic vascular surgery.

摘要

背景

对于不适合血管内治疗的慢性肠系膜缺血患者,可进行腹腔镜主动脉肠系膜旁路手术。本研究介绍了一系列有限的腹腔镜肠系膜动脉血运重建治疗肠系膜缺血的初步经验。

方法

对于既往血管内治疗失败或存在动脉闭塞及广泛钙化而无法进行安全血管内治疗的慢性肠系膜缺血(CMI)患者,提供腹腔镜肠系膜血运重建治疗。2015年10月至2018年11月,9例CMI患者接受了腹腔镜血运重建。除了人口统计学数据和治疗的围手术期结果外,在1、3、6和12个月时用双功超声评估移植物通畅情况,此后每年评估一次。对数据进行描述性分析。

结果

所有旁路均采用8mm环形增强型膨体聚四氟乙烯移植物以逆行方式(从肾下腹主动脉或髂动脉)构建至肠系膜上动脉或脾动脉(2例)。中位手术时间为356分钟(范围247 - 492分钟)。5例患者有血管内治疗失败史。腹腔镜技术成功率为78%,初次开放转换率为22%。在中位随访时间26个月(范围18 - 49个月)内,所有腹腔镜血运重建手术在出院后移植物均保持通畅。30天时原发性移植物通畅率为78%。原发性辅助移植物通畅率和继发性移植物通畅率分别为78%和100%。中位体重增加2kg(范围2 - 18kg),所有患者餐后疼痛和恶心症状均缓解。随访期间未观察到死亡病例。

结论

腹腔镜主动脉肠系膜血运重建治疗慢性肠系膜缺血手术是可行的,但需要仔细选择患者。这些手术应由有腹腔镜血管手术经验的血管外科医生在转诊中心进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/7098165/3720d2ded0b5/VHRM-16-87-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验